Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 6:17 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 3,800,983 5.700% | 253,900 (+7.16%) | Filing History |
| 2023-02-13 6:14 pm Sale | 2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,810,835 5.100% | -118,366 (-6.14%) | Filing History |
| 2023-02-13 6:13 pm Purchase | 2022-12-31 | 13G | Pyxis Oncology, Inc. PYXS | BIOTECHNOLOGY VALUE FUND L P | 2,938,851 8.400% | 1,147,500 (+64.06%) | Filing History |
| 2023-02-13 6:11 pm Purchase | 2022-12-31 | 13G | Ikena Oncology, Inc. IKNA | BIOTECHNOLOGY VALUE FUND L P | 2,503,071 6.900% | 704,700 (+39.19%) | Filing History |
| 2023-02-13 6:08 pm Sale | 2022-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM | BIOTECHNOLOGY VALUE FUND L P | 5,172 1.600% | -17,821 (-77.50%) | Filing History |
| 2023-02-13 6:05 pm Purchase | 2022-12-31 | 13G | Elevation Oncology, Inc. ELEV | BIOTECHNOLOGY VALUE FUND L P | 2,312,200 9.900% | 700,502 (+43.46%) | Filing History |
| 2023-02-13 6:02 pm Purchase | 2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE | BIOTECHNOLOGY VALUE FUND L P | 4,917,774 9.990% | 1,321,017 (+36.73%) | Filing History |
| 2023-02-13 6:00 pm Purchase | 2022-12-31 | 13G | Annexon, Inc. ANNX | BIOTECHNOLOGY VALUE FUND L P | 3,780,694 7.900% | 437,500 (+13.09%) | Filing History |
| 2023-02-13 5:57 pm Sale | 2022-12-31 | 13G | Alpine Immune Sciences, Inc. ALPN | BIOTECHNOLOGY VALUE FUND L P | 1,353,815 2.900% | -235,680 (-14.83%) | Filing History |
| 2023-02-13 5:55 pm Purchase | 2022-12-31 | 13G | Repare Therapeutics Inc. RPTX | BIOTECHNOLOGY VALUE FUND L P | 8,291,988 19.800% | 150,000 (+1.84%) | Filing History |
| 2023-02-13 5:53 pm Purchase | 2022-12-31 | 13G | AC Immune S.A. ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,428,379 8.900% | 366,000 (+5.18%) | Filing History |
| 2023-02-13 5:53 pm Purchase | 2022-12-31 | 13G | Viracta Therapeutics, Inc. VIRX | BIOTECHNOLOGY VALUE FUND L P | 3,833,785 9.980% | 102,041 (+2.73%) | Filing History |
| 2023-02-13 5:51 pm Sale | 2022-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | BIOTECHNOLOGY VALUE FUND L P | 75,280 1.900% | -25,642 (-25.41%) | Filing History |
| 2023-02-13 5:28 pm Purchase | 2023-02-03 | 13G | Structure Therapeutics Inc. GPCR | BIOTECHNOLOGY VALUE FUND L P | 12,660,518 11.100% | 12,660,518 (New Position) | Filing History |
| 2023-02-06 4:43 pm Purchase | 2023-01-25 | 13G | Jasper Therapeutics, Inc. JSPR | BIOTECHNOLOGY VALUE FUND L P | 990,000 9.100% | 990,000 (New Position) | Filing History |
| 2023-01-03 5:01 pm Purchase | 2022-12-22 | 13G | Zymeworks Inc. ZYME | BIOTECHNOLOGY VALUE FUND L P | 5,870,000 9.300% | 5,870,000 (New Position) | Filing History |
| 2022-12-23 5:08 pm Sale | 2022-12-21 | 13G | PHAXIAM Therapeutics S.A. PHXM | BIOTECHNOLOGY VALUE FUND L P | 22,993 7.400% | -28,199 (-55.08%) | Filing History |
| 2022-12-21 4:40 pm Purchase | 2022-12-19 | 13G | Third Harmonic Bio, Inc. THRD | BIOTECHNOLOGY VALUE FUND L P | 4,365,933 10.800% | 864,119 (+24.68%) | Filing History |
| 2022-12-16 4:45 pm Purchase | 2022-12-06 | 13G | NLS Pharmaceutics AG NLSP | BIOTECHNOLOGY VALUE FUND L P | 171,479 19.990% | 171,479 (New Position) | Filing History |
| 2022-12-05 4:45 pm Purchase | 2022-11-23 | 13G | Kura Oncology, Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 3,547,083 5.300% | 2,301,171 (+184.70%) | Filing History |